Paite Meisheng raises Series A for veterinary drug development
CITIC Group Agricultural Industry Fund led the financing, with Future Pet Research Institute participating.
Paite Meisheng has completed Series A financing led by CITIC Group Agricultural Industry Fund, with existing shareholder Future Pet Research Institute also investing. The company described the round as tens of millions of yuan without disclosing an exact amount.
The Nanjing business develops innovative veterinary medicines and formulations for pets. It plans to use the funding to advance its drug pipeline and expand its market presence.
By July 2026, its first innovative veterinary drug had entered clinical development. The company also develops pet health products through its subsidiary Pairuile.
Use of funds
Develop innovative veterinary medicines and expand sales